×
About 34,215 results

ALLMedicine™ HIV Infection Center

Research & Reviews  11,754 results

HIV-associated neurotoxicity and cognitive decline: Therapeutic implications.
https://doi.org/10.1016/j.pharmthera.2021.108047
Pharmacology & Therapeutics; Wallace DR

Dec 2nd, 2021 - As our understanding of changes to the neurological system has improved, it has become clear that patients who have contracted human immunodeficiency virus type 1 (HIV-1) can potentially suffer from a cascade of neurological issues, including neur...

Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospecti...
https://doi.org/10.1136/bmjopen-2020-048582
BMJ Open; Dijkstra M, Prins H et. al.

Dec 1st, 2021 - Initiation of combination antiretroviral therapy (cART) during acute or early HIV-infection (AEHI) limits the size of the viral reservoir and preserves immune function. This renders individuals who started cART during AEHI promising participants i...

Can I go back to work? A case of persistent SARS-CoV-2 with advanced untreated HIV infe...
https://doi.org/10.1177/09564624211051631
International Journal of STD & AIDS; Wenlock RD, Brown CS et. al.

Nov 30th, 2021 - We describe the case of a 30-year-old care home employee diagnosed with COVID-19 and acute untreated HIV-1. He was unable to return to work for 119 days due to concerns over transmission risk as his SARS-CoV-2 PCR remained detectable. This highlig...

Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines.
https://doi.org/10.1007/s11904-021-00590-x 10.1016/S0140-6736(20)30183-5 10.1016/j.jinf.2020.03.041 10.1016/S0140-6736(20)30566-3 10.1001/jama.2020.2648 10.1093/cid/ciaa415 10.1038/s41586-020-2700-3 10.1183/13993003.00547-2020 10.1016/S0002-9343(97)00003-X 10.1111/ctr.13511 10.2174/1874613601610010034 10.1016/j.ijid.2020.05.013 10.1016/S2352-3018(20)30143-0 10.1016/S2352-3018(20)30138-7 10.1126/science.abd1072 10.1016/S2352-3018(20)30211-3 10.1093/cid/ciaa863 10.1097/00126334-200310010-00016 10.1016/j.jcv.2014.11.030 10.1001/jama.2020.6775 10.1136/bmj.m1985 10.1093/cid/ciaa1605 10.1016/S2352-3018(20)30305-2 10.1001/jamanetworkopen.2020.37069 10.1093/cid/ciaa635 10.1016/S2213-2600(20)30076-X 10.1038/s41591-020-0819-2 10.1038/s41392-020-0148-4 10.1016/j.cell.2020.05.015 10.1016/j.cell.2020.08.017 10.1016/S1473-3099(20)30196-1 10.1038/s41586-020-2380-z 10.1038/s41590-020-00814-z 10.1126/sciadv.abf2467 10.1016/s0140-6736(21)00675-9 10.1038/s41586-020-2814-7 10.1056/NEJMc2032195 10.1126/science.abf4063 10.1001/jama.1989.03420020097023 10.1086/313985 10.4103/1817-1737.69106 10.1038/nrmicro2848 10.1128/jvi.76.10.5082-5093.2002 10.1093/cid/ciaa1339 10.1016/j.jcv.2013.09.015 10.1126/sciimmunol.abd7114 10.1016/j.chom.2020.04.009 10.1016/j.ijid.2020.04.060 10.1016/S2352-3018(21)00072-2 10.1146/annurev.immunol.21.120601.141053 10.7326/m20-3689 10.1128/jvi.74.21.10249-10255.2000 10.1038/nature05115 10.1084/jem.188.12.2205 10.1128/jvi.77.8.4911-4927.2003 10.1038/s41423-020-0402-2 10.1038/s41423-020-0401-3 10.1016/j.immuni.2020.12.002 10.1126/sciimmunol.abe4782 10.1038/s41422-020-0391-9 10.1007/s11904-010-0066-0 10.1038/s41586-021-03631-y 10.1126/science.abd4585 10.1126/scitranslmed.abd3876 10.1056/nejm198308253090803 10.1172/jci115621 10.1126/science.1111781 10.1084/jem.20072683 10.1038/s41423-020-00542-2 10.1016/j.immuni.2013.10.001 10.1128/jvi.01844-08 10.1086/652749 10.1038/s41586-020-2588-y 10.1016/j.chom.2020.05.008 10.1016/j.virol.2007.10.042 10.1073/pnas.0611353104 10.1126/science.abd4570 10.1093/cid/cir627 10.1002/jmv.26321 10.1002/jmv.25955 10.1097/qad.0000000000002639 10.1073/pnas.0403596101 10.1128/aac.03011-14 10.1016/j.antiviral.2020.104786 10.1056/NEJMoa2001282 10.1126/science.277.5322.112 10.1084/jem.188.2.233 10.1097/00126334-200212150-00003 10.1086/374786 10.1097/qai.0000000000002570 10.1016/S0140-6736(20)32156-5 10.1084/jem.20081786 10.1128/JVI.06175-11 10.1016/j.vaccine.2011.05.025 10.1016/S0140-6736(20)31605-6 10.1016/S0140-6736(21)00234-8 10.1056/NEJMoa2101544 10.1056/NEJMoa2103055
Current HIV/AIDS Reports; Yang Y, Iwasaki A

Nov 30th, 2021 - The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into a global pandemic that affect the health of hundreds of millions worldwide. In particular, SARS-CoV-2 infection in people with chronic human immune deficiency viru...

see more →

Guidelines  34 results

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Reco...
https://doi.org/10.1001/jama.2020.17025
JAMA Saag MS, Gandhi RT et. al.

Oct 15th, 2020 - Data on the use of antiretroviral drugs, including new drugs and formulations, for the treatment and prevention of HIV infection continue to guide optimal practices. To evaluate new data and incorporate them into current recommendations for initia...

Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recomm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147901
MMWR. Morbidity and Mortality Weekly Report; Tepper NK, Curtis KM et. al.

Apr 10th, 2020 - "U.S. Medical Eligibility Criteria for Contraceptive Use" (U.S. MEC) 2016 provides evidence-based guidance for the safe use of contraceptive methods among U.S. women with certain characteristics or medical conditions (1). The U.S. MEC is adapted f...

Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement.
https://doi.org/10.1001/jama.2019.6587
JAMA , Owens DK et. al.

Jun 12th, 2019 - Approximately 1.1 million persons in the United States are currently living with HIV, and more than 700 000 persons have died of AIDS since the first cases were reported in 1981. There were approximately 38 300 new diagnoses of HIV infection in 20...

Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Tas...
https://doi.org/10.1001/jama.2019.6390
JAMA , Owens DK et. al.

Jun 12th, 2019 - An estimated 1.1 million individuals in the United States are currently living with HIV, and more than 700 000 persons have died of AIDS since the first cases were reported in 1981. In 2017, there were 38 281 new diagnoses of HIV infection reporte...

Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a pos...
https://doi.org/10.1007/s00198-018-4794-0
Osteoporosis International : a Journal Established as Res... Biver E, Calmy A et. al.

Jan 4th, 2019 - Life expectancy of people living with HIV (PLWH) is reaching similar length as in the general population. Accordingly, age-related comorbidities, including osteoporosis, are increasing. Fracture risk is higher and increases approximately 10 years ...

see more →

Drugs  95 results see all →

Clinicaltrials.gov  587 results

Gene Expression in Chronic Venous Leg Ulcers
https://clinicaltrials.gov/ct2/show/NCT05134597

Nov 25th, 2021 - Chronic Venous Disease (CVD) is a widespread clinical condition widely spread in the western countries, with a prevalence ranging from 10% in adults younger than 30 years of age to nearly 80% for individuals >70 years of age. CVD clinical manifest...

PET Imaging and Lymph Node Assessment of IRIS in People With AIDS
https://clinicaltrials.gov/ct2/show/NCT02147405

Nov 24th, 2021 - Immune reconstitution inflammatory syndrome (IRIS) in HIV infection represents a paradoxical, frequently inflammatory, immune response after initiation of antiretroviral (ART) therapy. The immunopathogenesis of IRIS remains elusive partially due t...

Camu Camu in ART-treated People Living With HIV
https://clinicaltrials.gov/ct2/show/NCT04058392

Nov 23rd, 2021 - Persons living with HIV and receiving antiretroviral therapy (ART) remain with inflammation leading to higher risks of cardiovascular diseases, fatty liver and cancer. It has been observed in colitis and in HIV infection that abnormal composition ...

Study to Assess the Effectiveness and Safety of Lenacapavir for Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis
https://clinicaltrials.gov/ct2/show/NCT04925752

Nov 22nd, 2021 - The primary objective of this study is to evaluate the efficacy of lenacapavir (LEN) in preventing the risk of human immunodeficiency virus (HIV) infection relative to the background HIV incidence rate. The study will be conducted in 2 parts: a cr...

Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
https://clinicaltrials.gov/ct2/show/NCT02384395

Nov 22nd, 2021 - The study will be conducted at the University of North Carolina in Chapel Hill, NC and Duke University in Durham, NC. The investigators plan to enroll up to 44 participants who will be enrolled for 96 weeks and will receive DTG/3TC/ABC FDC. The in...

see more →

News  1,209 results

Confused About COVID-19 Boosters?
https://www.medscape.com/viewarticle/962969

Nov 15th, 2021 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. JOHN WHYTE: Are you confused about whether you should get a COVID vaccine booster shot? Let me help try to unpack it for you. Why do some people need boosters? A...

Year in Review: HIV
https://www.medpagetoday.com/hivaids/hivaids/95613

Nov 12th, 2021 - Long-acting therapies headlined a year of continued drug development, both in the treatment and prevention of HIV. Meanwhile, CDC recommended a third dose of a COVID-19 mRNA vaccine for certain patients living with advanced or untreated HIV to boo...

More Than Half of People Living With HIV Have Coronary Plaque
https://www.medscape.com/viewarticle/962421

Nov 5th, 2021 - More than half of people living with HIV and suppressed viral loads nonetheless had imaging-confirmed coronary artery disease — and despite longtime use of HIV drugs that have been associated with cardiovascular trouble, none of those drugs were i...

ACIP Recommends Universal HBV Vaccination for Adults Under 60, Expands Recommendations for Vaccines Against Orthopoxviruses and Ebola
https://www.medscape.com/viewarticle/962310

Nov 4th, 2021 - The Advisory Committee on Immunization Practices (ACIP) of the US Centers for Disease Control and Prevention has unanimously voted to recommend universal hepatitis B (HBV) immunization in all unvaccinated adults aged 59 or younger. The group also ...

Answers to Questions About the Latest Booster Recommendations
https://www.medscape.com/viewarticle/961703

Oct 27th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Now that federal regulators have issued their edicts on booster doses for the COVID-19 vaccine, many people have many questions. Here are some ans...

see more →

Patient Education  7 results see all →